Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors

ZL-1310 is an innovative ADC targeting DLL3, a promising therapeutic target in small cell lung cancer and other DLL3+ solid tumors


Data will be shared in a poster presentation at the European Lung...

Related Keywords

Czech Republic ,United States ,Prague ,Praha ,Hlavníesto ,China ,Rafaelg Amado ,Orgilmma Regzedmma ,Lindan Liu ,Global Oncology Research ,Zai Lab Forward ,Prague Congress Centre ,Congress Hall Foyer ,Exchange Commission ,Zai Lab ,Zai Lab Limited ,European Lung Cancer Congress ,Medilink Therapeutic ,Senior Vice President ,Biologics Discovery ,Small Cell Lung Cancer ,Private Securities Litigation Reform Act ,Neuroendocrine Tumor ,Cancer Net ,Markets ,